EQS-News: Kazia Therapeutics Ltd Kazia Therapeutics talks positive pre-clinical data for EVT801 06.12.2022 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 Jonathan@proactiveinvestors.com 06.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
Language: | English |
Company: | Kazia Therapeutics Ltd |
United States | |
ISIN: | AU000000KZA9 |
EQS News ID: | 1506611 |
End of News | EQS News Service |
|
1506611 06.12.2022 CET/CEST